Tab. V.
Effect of phosphatidylserine on neurological conditions.
| Neurological conditions | Subjects | Nutrients | Findings | References |
|---|---|---|---|---|
| Alzheimer’s disease | Aged patients with AD and dementia | Soy lecithin-derived phosphatidylserine plus phosphatidic acid | Improved cognition, mood, and memory | [58] |
| Attention deficit hyperactivity disorder (ADHD) | Children with ADHD | Phosphatidylserine | Improved short-term auditory memory and ADHD symptoms | [59] |
| Premenstrual syndrome (PMS) | 40 women age 18-45 years diagnosed with PMS | 400 mg PS + 400 mg PA per day or a matching placebo | Significant reduction in PMS symptoms | [60] |
| Cognitive impairment | Elderly persons with impaired memory | 100 mg/day phosphatidylserine enriched with docosahexaenoic acid (PS-DHA) | May improve or maintain cognitive status | [61] |
| Cognitive function improvement | Elderly persons with impaired memory without dementia | Phosphatidylserine enriched with docosahexaenoic acid (PS-DHA) | May improve cognitive performance | [62] |
| Acute cognitive effects | Healthy young volunteers | Ginkgo biloba extract with soy-derived PS | Significantly improved memory task speed and improved secondary memory | [63] |
| Cognition and cortical activity after mental stress | Healthy subjects doing cognitive tasks under induced stress in a test–re-test design | Phosphatidylserine supplementation | Continued supplementation significantly was connected with a more relaxed state compared to the controls | [64] |
| Age-related cognitive function | 130 elderly persons with cognitive impairment | PS derived from soybean 300 mg/day | Safely improved cognitive function | [65] |
| 494 elderly persons with cognitive impairment | 300 mg/day PS supplements | Improved cognitive function in 6 months | [66] |